B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MYO3A

MOLECULAR TARGET

myosin IIIA

UniProt: Q8NEV4NCBI Gene: 539049 compounds

MYO3A (myosin IIIA) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MYO3A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1foretinib4.3476
2bosutinib4.0858
3bi 25364.0154
4tae 6843.4330
5lestaurtinib3.0420
6kw 24492.6413
7ast 4872.5612
8su 0148132.208
9Axitinib0.691

About MYO3A as a Drug Target

MYO3A (myosin IIIA) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented MYO3A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MYO3A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.